• Skip to main content
  • Skip to secondary menu
  • Skip to primary sidebar
  • Skip to secondary sidebar
  • Skip to footer

  • Opinion
  • Health IT
    • Behavioral Health
    • Care Coordination
    • EMR/EHR
    • Interoperability
    • Patient Engagement
    • Population Health Management
    • Revenue Cycle Management
    • Social Determinants of Health
  • Digital Health
    • AI
    • Blockchain
    • Precision Medicine
    • Telehealth
    • Wearables
  • Startups
  • M&A
  • Value-based Care
    • Accountable Care (ACOs)
    • Medicare Advantage
  • Life Sciences
  • Research

RWJUH Opens Center for Innovation for Medical Research

by Jasmine Pennic 09/16/2022 Leave a Comment

  • LinkedIn
  • Twitter
  • Facebook
  • Email
  • Print
RWJUH Opens Center for Innovation for Medical Research

What You Should Know:

– Robert Wood Johnson University Hospital (RWJUH), an RWJBarnabas Health facility, and Rutgers Robert Wood Johnson Medical School (RWJMS) launched a new model for medical research and innovation today at the grand opening of its Center for Innovation, located on the main campus of the hospital.

– The Center for Innovation is a partnership between RWJUH and Rutgers RWJMS to bring together clinicians, researchers and private industry to invent and develop new technologies that address both complex and common healthcare issues.

Developing Innovative Clinical Trials

The ultimate goal is to develop innovative clinical trials that yield medical breakthroughs to improve preventive care and health outcomes for patients. The center’s concept and design were led by the Cardiovascular Services team under the direction of Partho Sengupta, MD, FACC, but it is designed for use across all clinical teams and disciplines. Dr. Sengupta is the Henry Rutgers Professor of Cardiology and Chief of the Division of Cardiovascular Disease and Hypertension at RWJMS, and Chief of Cardiology at RWJUH, and is a member of the Combined Medical Group of RWJBarnabas Health and Rutgers Health. The center was made possible via donor funding from the RWJ University Hospital Foundation.

The center’s core team for digital transformation will be led by Naveena Yanamala, PhD, Director of Artificial Intelligence and Data Science in the Division of Cardiovascular Disease and Hypertension, RWJMS. Examples of the technology under development at the Center include the use of ear buds to provide real-time heart rhythm metrics such as heart rate and heart rate variability; a medical vest with sensors that can be placed on a patient to record – without blood draw and analysis – “markers” or vital information that may indicate a heart attack; and hand-held mobile EKG technology as a replacement for use of a stethoscope.

Current Clinical Trials

The Cardiovascular Services team has two clinical trials underway, with more expected to initiate by the end of the year. One trial is evaluating an FDA-approved remote robotic ultrasound system to effectively capture expert quality cardiac ultrasound images remotely. The second is an artificial intelligence mobile health trial of a digital platform to study the use of wearable sensors that collect health data from patients diagnosed with high blood pressure and/or early-stage heart failure. The information is then used to initiate guideline-directed medical treatment remotely.

“We’re advancing the design of a technology and innovation hub where diverse people including RWJUH and Rutgers RWJMS faculty, community physicians and staff, can come together to create new ideas and designs for clinical care and identify technologies that help find solutions to healthcare challenges,” Dr. Sengupta says. “It’s important to create a space and environment that is optimized for creativity, innovative thinking and collaboration.”

RWJUH President and Chief Executive Officer Bill Arnold said, “The collaboration and innovation that will take place within this center is what differentiates the academic medical center’s mission to not just treat illness, but to analyze it, create new pathways to prevent it and then share the solutions across the global medical community. Bringing private industry into this mix adds the crucial ingredient of new technologies – whether they are widely used already or in the incubator phase at a startup. It is exciting to imagine what we can create to improve the health of our communities and to change the course of the health of our vulnerable populations.”

  • LinkedIn
  • Twitter
  • Facebook
  • Email
  • Print

Tagged With: Artificial Intelligence, Blood Pressure, Clinical Trials, digital transformation, FDA, Heart, Hypertension, MD, medical group, mobile health, model, PhD, physicians, sensors, Ultrasound, University Hospital, Vital

Tap Native

Get in-depth healthcare technology analysis and commentary delivered straight to your email weekly

Reader Interactions

Primary Sidebar

Subscribe to HIT Consultant

Latest insightful articles delivered straight to your inbox weekly.

Submit a Tip or Pitch

Featured Insights

2025 EMR Software Pricing Guide

2025 EMR Software Pricing Guide

Featured Interview

Paradigm Shift in Diabetes Care with Studio Clinics: Q&A with Reach7 Founder Chun Yong

Most-Read

Medtronic to Separate Diabetes Business into New Standalone Company

Medtronic to Separate Diabetes Business into New Standalone Company

White House, IBM Partner to Fight COVID-19 Using Supercomputers

HHS Sets Pricing Targets for Trump’s EO on Most-Favored-Nation Drug Pricing

23andMe to Mine Genetic Data for Drug Discovery

Regeneron to Acquire Key 23andMe Assets for $256M, Pledges Continuity of Consumer Genome Services

CureIS Healthcare Sues Epic: Alleges Anti-Competitive Practices & Trade Secret Theft

The Evolving Role of Physician Advisors: Bridging the Gap Between Clinicians and Administrators

The Evolving Physician Advisor: From UM to Value-Based Care & AI

UnitedHealth Group Names Stephen Hemsley CEO as Andrew Witty Steps Down

UnitedHealth CEO Andrew Witty Steps Down, Stephen Hemsley Returns as CEO

Omada Health Files for IPO

Omada Health Files for IPO

Blue Cross Blue Shield of Massachusetts Launches "CloseKnit" Virtual-First Primary Care Option

Blue Cross Blue Shield of Massachusetts Launches “CloseKnit” Virtual-First Primary Care Option

Osteoboost Launches First FDA-Cleared Prescription Wearable Nationwide to Combat Low Bone Density

Osteoboost Launches First FDA-Cleared Prescription Wearable Nationwide to Combat Low Bone Density

2019 MedTech Breakthrough Award Category Winners Announced

MedTech Breakthrough Announces 2025 MedTech Breakthrough Award Winners

Secondary Sidebar

Footer

Company

  • About Us
  • Advertise with Us
  • Reprints and Permissions
  • Submit An Op-Ed
  • Contact
  • Subscribe

Editorial Coverage

  • Opinion
  • Health IT
    • Care Coordination
    • EMR/EHR
    • Interoperability
    • Population Health Management
    • Revenue Cycle Management
  • Digital Health
    • Artificial Intelligence
    • Blockchain Tech
    • Precision Medicine
    • Telehealth
    • Wearables
  • Startups
  • Value-Based Care
    • Accountable Care
    • Medicare Advantage

Connect

Subscribe to HIT Consultant Media

Latest insightful articles delivered straight to your inbox weekly

Copyright © 2025. HIT Consultant Media. All Rights Reserved. Privacy Policy |